首页> 美国卫生研究院文献>Acta Naturae >Identification of Novel IGF1R Kinase Inhibitors by Molecular Modeling and High-Throughput Screening
【2h】

Identification of Novel IGF1R Kinase Inhibitors by Molecular Modeling and High-Throughput Screening

机译:通过分子建模和高通量筛选鉴定新型IGF1R激酶抑制剂

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of this study was to identify small molecule compounds that inhibit the kinase activity of the IGF1 receptor and represent novel chemical scaffolds, which can be potentially exploited to develop drug candidates that are superior to the existing experimental anti-IGF1R therapeuticals. To this end, targeted compound libraries were produced by virtual screening using molecular modeling and docking strategies, as well as the ligand-based pharmacophore model. High-throughput screening of the resulting compound sets in a biochemical kinase inhibition assay allowed us to identify several novel chemotypes that represent attractive starting points for the development of advanced IGF1R inhibitory compounds.
机译:这项研究的目的是确定抑制IGF1受体激酶活性并代表新型化学支架的小分子化合物,可以潜在地开发出优于现有实验性抗IGF1R治疗药物的候选药物。为此,使用分子建模和对接策略以及基于配体的药效团模型,通过虚拟筛选产生了目标化合物库。在生化激酶抑制试验中对所得化合物进行高通量筛选,使我们能够鉴定出几种新型化学型,这些化学型代表了开发高级IGF1R抑制性化合物的有吸引力的起点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号